| Nov 11 |
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
|
| Nov 11 |
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
|
| Nov 11 |
FDA lifts pause on Novavax flu vaccine trials
|
| Nov 6 |
Novavax in $123.8M settlement with U.K. agency over COVID vaccine deal
|
| Nov 6 |
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
|
| Nov 5 |
Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
| Nov 4 |
Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024
|
| Oct 31 |
Novavax Q3 Earnings A Week Away - Time To Accept A New Reality
|
| Oct 29 |
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
|
| Oct 26 |
It’s Time to Get Your Covid and Flu Shots. Everything to Know About This Year’s Vaccines.
|
